Literature DB >> 27629291

Study of apoptosis-related interactions in colorectal cancer.

Himanshu Arora1, Rehana Qureshi2, M A Rizvi2, Sharad Shrivastava3, Mordhwaj S Parihar3.   

Abstract

Abnormalities in apoptotic functions contribute to the pathogenesis of colorectal cancer. In this study, molecular interactions behind the apoptotic regulation have been explored. For this purpose, enrichment analysis was performed considering microRNAs (miRNAs) that putatively target TP53 and altered during colon cancer. This revealed gene associated with both TP53 and miRNAs. Further analysis showed that a significant molecular interaction between the shortlisted candidates (TP53, miR-143, KRAS, BCL2, and PLK1) exists. Mutation study was conducted to confirm the clinical relevance of candidates. It showed that the mutation extent does not significantly alter survival in patients thus making these candidates suitable as drug targets. Overall, we showed the importance of interactions between TP53, miR-143, KRAS, BCL2, and PLK1 with respect to colorectal cancer using bioinformatics approach.

Entities:  

Keywords:  Apoptosis; Colorectal cancer; TP53; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27629291     DOI: 10.1007/s13277-016-5363-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  60 in total

1.  Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma.

Authors:  Niamh Lynam-Lennon; John V Reynolds; Graham P Pidgeon; Joanne Lysaght; Laure Marignol; Stephen G Maher
Journal:  Radiat Res       Date:  2010-10-04       Impact factor: 2.841

2.  Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.

Authors:  R Knecht; R Elez; M Oechler; C Solbach; C von Ilberg; K Strebhardt
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

3.  miR-143 regulates proliferation and apoptosis of colorectal cancer cells and exhibits altered expression in colorectal cancer tissue.

Authors:  Fan Yang; Yi-Qiang Xie; Song-Qi Tang; Xian-Bo Wu; Hai-Yan Zhu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer.

Authors:  Phillip J Gray; David J Bearss; Haiyong Han; Raymond Nagle; Ming-Sound Tsao; Nicholas Dean; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2004-05       Impact factor: 6.261

5.  Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity.

Authors:  Thomas D Pfister; William C Reinhold; Keli Agama; Shalu Gupta; Sonny A Khin; Robert J Kinders; Ralph E Parchment; Joseph E Tomaszewski; James H Doroshow; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

6.  Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies.

Authors:  Michael Steckel; Miriam Molina-Arcas; Britta Weigelt; Michaela Marani; Patricia H Warne; Hanna Kuznetsov; Gavin Kelly; Becky Saunders; Michael Howell; Julian Downward; David C Hancock
Journal:  Cell Res       Date:  2012-05-22       Impact factor: 25.617

Review 7.  MicroRNA: potential targets for the development of novel drugs?

Authors:  Wei Wu
Journal:  Drugs R D       Date:  2010

8.  Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells.

Authors:  Rong Zhu; Yongtao Yang; Yin Tian; Jianying Bai; Xin Zhang; Xiaohuan Li; Zhihong Peng; Yonghong He; Lei Chen; Qiong Pan; Dianchun Fang; Wensheng Chen; Chen Qian; Xiuwu Bian; Rongquan Wang
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  A novel dynamic impact approach (DIA) for functional analysis of time-course omics studies: validation using the bovine mammary transcriptome.

Authors:  Massimo Bionaz; Kathiravan Periasamy; Sandra L Rodriguez-Zas; Walter L Hurley; Juan J Loor
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

10.  Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature.

Authors:  Yolanda Sánchez; Victor Segura; Oskar Marín-Béjar; Alejandro Athie; Francesco P Marchese; Jovanna González; Luis Bujanda; Shuling Guo; Ander Matheu; Maite Huarte
Journal:  Nat Commun       Date:  2014-12-19       Impact factor: 14.919

View more
  9 in total

1.  Effects of Huaier Extract on Ameliorating Colitis-Associated Colorectal Tumorigenesis in Mice.

Authors:  Yi-Feng Zou; Yu-Ming Rong; Ze-Xian Chen; Zhi-Hong Shen; Xi Chen; Ying-Xin Tan; Jing-Rong Weng; Xiao-Ming Huang; Xu-Tao Lin
Journal:  Onco Targets Ther       Date:  2020-08-26       Impact factor: 4.147

2.  Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.

Authors:  Jiang-Hui Zeng; Liang Liang; Rong-Quan He; Rui-Xue Tang; Xiao-Yong Cai; Jun-Qiang Chen; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-03-07

3.  Novel miRNA-mRNA interactions conserved in essential cancer pathways.

Authors:  Eduardo Andrés-León; Ildefonso Cases; Sergio Alonso; Ana M Rojas
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

4.  RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.

Authors:  Chao Xiao; Yupeng Wang; Miao Zheng; Jian Chen; Guohe Song; Zhijie Zhou; Chongzhi Zhou; Xing Sun; Lin Zhong; Erxun Ding; Yi Zhang; Liu Yang; Gang Wu; Shifeng Xu; Hong Zhang; Xiaoliang Wang
Journal:  Cancer Sci       Date:  2018-03-10       Impact factor: 6.716

5.  lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells.

Authors:  Fei Liu; Jianhui Jia; Liping Sun; Qingrui Yu; Hongyan Duan; Dexin Jiao; Zhiqiang Gong; Shendong Zhu; Kexin Jiang; Yijiang He; Liping Chen; Yanni Zhang; Han Sun
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

6.  Silencing Lin28 promotes apoptosis in colorectal cancer cells by upregulating let‑7c targeting of antiapoptotic BCL2L1.

Authors:  Haogang Zhang; Yaguang Zong; Gongcai Qiu; Ruichun Jia; Xunzheng Xu; Fujing Wang; Dequan Wu
Journal:  Mol Med Rep       Date:  2018-01-25       Impact factor: 2.952

7.  Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.

Authors:  Rui-Xue Tang; Wen-Jie Chen; Rong-Quan He; Jiang-Hui Zeng; Liang Liang; Shi-Kang Li; Jie Ma; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-04-13

8.  Mitotic and apoptotic activity in colorectal neoplasia.

Authors:  Darina Kohoutova; Jaroslav Pejchal; Jan Bures
Journal:  BMC Gastroenterol       Date:  2018-05-18       Impact factor: 3.067

Review 9.  Current and future biomarkers in colorectal cancer.

Authors:  George Zarkavelis; Stergios Boussios; Alexandra Papadaki; Konstantinos H Katsanos; Dimitrios K Christodoulou; George Pentheroudakis
Journal:  Ann Gastroenterol       Date:  2017-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.